Exacerbation of asthma due to inadvertent use of a dummy inhaler
Asthma is a common airways disease. Fortunately most patients respond well to inhaled therapy. Regular use of a combination inhaler delivering corticosteroid and a long-acting beta-2 agonist, is the mainstay of treatment and allows asthmatics to live a relatively normal life. However, management of...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Respiratory Medicine Case Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213007118301187 |
id |
doaj-2786917dd5df47438b8592ea4fcc8f3b |
---|---|
record_format |
Article |
spelling |
doaj-2786917dd5df47438b8592ea4fcc8f3b2020-11-25T00:08:00ZengElsevierRespiratory Medicine Case Reports2213-00712018-01-0124133134Exacerbation of asthma due to inadvertent use of a dummy inhalerSyed Mohammad Tariq0Department of Respiratory Medicine, Luton & Dunstable University Hospital, Lewsey Road, Luton LU4 0DZ, Bedfordshire, United KingdomAsthma is a common airways disease. Fortunately most patients respond well to inhaled therapy. Regular use of a combination inhaler delivering corticosteroid and a long-acting beta-2 agonist, is the mainstay of treatment and allows asthmatics to live a relatively normal life. However, management of asthma depends not only on the choice of drug/inhaler but also on patient compliance and optimal inhaler technique. This report describes a patient who continued to deteriorate despite adhering to prescribed treatment and demonstrating a good inhaler technique. Unfortunately the combination inhaler she was taking inadvertently was a designated placebo device for a branded product. This error was identified and corrected only after she was admitted with an asthma attack. Keywords: Asthma, Beta-2 agonist, Corticosteroid, Dummy inhaler, Exacerbationhttp://www.sciencedirect.com/science/article/pii/S2213007118301187 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Syed Mohammad Tariq |
spellingShingle |
Syed Mohammad Tariq Exacerbation of asthma due to inadvertent use of a dummy inhaler Respiratory Medicine Case Reports |
author_facet |
Syed Mohammad Tariq |
author_sort |
Syed Mohammad Tariq |
title |
Exacerbation of asthma due to inadvertent use of a dummy inhaler |
title_short |
Exacerbation of asthma due to inadvertent use of a dummy inhaler |
title_full |
Exacerbation of asthma due to inadvertent use of a dummy inhaler |
title_fullStr |
Exacerbation of asthma due to inadvertent use of a dummy inhaler |
title_full_unstemmed |
Exacerbation of asthma due to inadvertent use of a dummy inhaler |
title_sort |
exacerbation of asthma due to inadvertent use of a dummy inhaler |
publisher |
Elsevier |
series |
Respiratory Medicine Case Reports |
issn |
2213-0071 |
publishDate |
2018-01-01 |
description |
Asthma is a common airways disease. Fortunately most patients respond well to inhaled therapy. Regular use of a combination inhaler delivering corticosteroid and a long-acting beta-2 agonist, is the mainstay of treatment and allows asthmatics to live a relatively normal life. However, management of asthma depends not only on the choice of drug/inhaler but also on patient compliance and optimal inhaler technique. This report describes a patient who continued to deteriorate despite adhering to prescribed treatment and demonstrating a good inhaler technique. Unfortunately the combination inhaler she was taking inadvertently was a designated placebo device for a branded product. This error was identified and corrected only after she was admitted with an asthma attack. Keywords: Asthma, Beta-2 agonist, Corticosteroid, Dummy inhaler, Exacerbation |
url |
http://www.sciencedirect.com/science/article/pii/S2213007118301187 |
work_keys_str_mv |
AT syedmohammadtariq exacerbationofasthmaduetoinadvertentuseofadummyinhaler |
_version_ |
1725417174282010624 |